Novel therapeutic avenues for therapy-resistant prostate cancer: a review
XU Ling-fan
William Butler
HUANG Jiao-ti
Abstract：Although hormonal therapy is effective initially for metastatic prostate cancer( PCa) , therapy resist-ance invariably occurs. Our team has been dedicated to investigating potential mechanisms and exploiting novel thera-peutic managements for those advanced patients who have run out of treatment of choice for decades. Our study scopes mainly focus on tumor biomarker identification, neuroendocrine differentiation and tumor metabolism. This review sum-marizes some of our key findings to advance understandings of how PCa progresses and what potential treatment regi-mens are.
Keywords：Prostate cancerTherapeutic resistanceTumor biomarkerTumor metabolism
Publication Date：2021-07-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 642-646 )